US Patent Issued to Celestial Therapeutics on Oct. 6 for "Methods of preparation of pan TLR antagonistic liposomal-LNP formulations and uses thereof" (California Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,920, issued on Oct. 6, was assigned to Celestial Therapeutics Inc. (Irvine, Calif.).

"Methods of preparation of pan TLR antagonistic liposomal-LNP formulations and uses thereof" was invented by Ajay Gupta (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A lipid nanoparticle (LNP) composition is provided. The composition includes a messenger RNA (mRNA) molecule; a lipid carrier system; and a toll-like receptor (TLR) antagonist."

The patent was filed on Nov. 6, 2023, under Application No. 18/387,453.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HI...